Bringing
quantitative neuroimaging
to clinical settings
for better patient care
CorticoMetrics’ FDA 510(k)-cleared product, called THINQ™, is not currently offered for sale. It is indicated for clinical use by neurologists, radiologists and neuroradiologists in the post-acquisition quantitative analysis of MRI brain scans.
product and technology
THINQ targets problems faced by radiologists and neurologists
Product
CorticoMetrics’ FDA 510(k)-cleared product, called THINQ™, is not currently offered for sale.
Technology
Clinical decision-making in neuroradiology is often based on qualitative assessment…
About us
AI-based software for advanced imaging
CorticoMetrics was formed in 2012 to commercialize neuroimaging analysis software developed at the Massachusetts General Hospital (MGH), known to researchers worldwide as FreeSurfer. It was co-founded by Dr. Bruce Fischl, the Director of the Laboratory for Computational Neuroimaging (home of FreeSurfer) and Mr. Nick Schmansky, formerly the lab’s Lead Software Engineer.
Our Team
Experienced Leadership in Driving Innovation
Nick Schmansky
Co-Founder & CEO
Bruce Fischl, PhD
Co-Founder & Scientific Advisor
Lee Tirrell
Software Engineer & Data Scientist
Karen Roberts, PhD
Business Advisor
Our technology aims to improve the overall quality of patient outcome
THINQ, the product created by CorticoMetrics through prior SBIR/STTR grants, targets this problem faced by
radiologists and neurologists by quantifying the size of critical brain structures and presenting the measures
alongside normative reference data.
